Dynatronics - DYNT Stock Forecast, Price & News

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company provides therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. It also offers power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, and other related equipment. In addition, the company provides clinical supplies, including exercise bands and tubings, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals, as well as online. It also exports its products to approximately 30 countries. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Analyst Ratings Changes

A number of brokerages have recently weighed in on DYNT. StockNews.com started coverage on shares of Dynatronics in a report on Tuesday, August 9th. They set a "hold" rating for the company. Lake Street Capital initiated coverage on Dynatronics in a research note on Wednesday, July 27th. They set a "buy" rating and a $4.00 target price for the company. One research analyst has rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Dynatronics currently has a consensus rating of "Moderate Buy" and an average price target of $3.50.

Dynatronics Price Performance

Shares of Dynatronics stock traded up $0.02 during midday trading on Monday, hitting $0.64. 21,074 shares of the company traded hands, compared to its average volume of 40,344. The firm's fifty day moving average price is $0.65 and its 200-day moving average price is $0.70. The stock has a market cap of $11.65 million, a price-to-earnings ratio of -62,950.00 and a beta of 0.14. Dynatronics has a 12 month low of $0.43 and a 12 month high of $1.62. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.89 and a current ratio of 2.03.

Dynatronics (NASDAQ:DYNT - Get Rating) last posted its earnings results on Thursday, May 12th. The medical equipment provider reported ($0.09) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.09). Dynatronics had a net margin of 1.11% and a return on equity of 2.99%. The firm had revenue of $10.32 million for the quarter, compared to analysts' expectations of $10.50 million. As a group, sell-side analysts forecast that Dynatronics will post -0.24 earnings per share for the current year.